The therapeutic potential of Crocus sativus Linn.: A comprehensive narrative review of clinical trials.
Neda RoshanravanSamad Ghaffari BavilPublished in: Phytotherapy research : PTR (2021)
Crocus sativus Linn. (Saffron) is valued worldwide for its potential use in the management of various degenerative disorders, including cardiovascular diseases (CVDs), diabetes, cancer, metabolic syndrome (MetS), neurodegenerative diseases, immune disorders, and sexual dysfunction. Previous reports, based on clinical trials, suggest that crocetin, crocin, picrocrocin, and safranal are the main bioactive components of saffron with antioxidant, anti-inflammatory, and anti-apoptotic effects. In this comprehensive narrative review, we studied the recent clinical trials, investigating the medicinal applications of saffron and/or its components. The present results can provide important insights into the potential of saffron in preventing and treating different disorders, with a special focus on the underlying cellular and molecular mechanisms. However, further high-quality studies are needed to firmly establish the clinical efficacy of saffron in treating some degenerative diseases.
Keyphrases
- clinical trial
- anti inflammatory
- cardiovascular disease
- metabolic syndrome
- phase ii
- oxidative stress
- type diabetes
- cell death
- mental health
- double blind
- cardiovascular risk factors
- squamous cell carcinoma
- insulin resistance
- randomized controlled trial
- coronary artery disease
- skeletal muscle
- risk assessment
- climate change
- cardiovascular events
- lymph node metastasis